Viewpoint: Why we shouldn’t be deterred by CRISPR’s ‘rollercoaster year’

shutterstock e
Image credit: Shutterstock

Despite spooking investors, new insights into DNA repair and the CRISPR gene-editing system are part and parcel of its progress from research tool to human therapy.

It’s been a rollercoaster year for companies developing CRISPR gene-editing therapies. In January, a study posted on the preprint server bioRxiv raised concerns about the potential immunogenicity of CRISPR–Cas9. In March, Nature Methods retracted a study that had suggested unexpected extensive off-target mutations arising from Cas9 activity in mice. In June, two studies in Nature Medicine revealed a role for the tumor suppressor protein p53 in antagonizing Cas9 genome editing. Now a study published in our pages by Allan Bradley and colleagues reports that in addition to off-target mutations, Cas9 can sometimes induce extensive on-target DNA damage, including large deletions, inversions and insertions.

…

Many companies are already exploring solutions to these concerns. At UMass’ RNA Therapeutics meeting in May, Caribou Biosciences disclosed efforts to address off-target issues by chemical modifications and base substitutions in the guide RNA. Others are improving the specificity of Cas9 through combined rational design, directed evolution and screening for more selective variants.

…

[O]ur knowledge of CRISPR–Cas gene editing and DNA repair is progressing. The picture may not be as clear as we would like. But rarely in biology does anything turn out to be as neat and simple as we imagine.

Read full, original post: Keep calm and edit on

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Children’s Health Defense Press Conference
As measles deaths among the unvaccinated hit a 35-year high, Kennedy-founded Children’s Health Defense bizarrely blames doctors for slow-walking a cure
eden green vertical farm facility
Why vertical farming is not the panacea for our food production crisis that its proponents claim
Contrasting Portraits and Family Story
Congressional investigation targets RFK Jr.: Documents show HHS chief lied multiple times during his confirmation hearings
Professional Portrait Earth Backdrop
Viewpoint: November 13 is the long-predicted global doomsday. How a respected scientist got population growth catastrophe predictions so spectacularly wrong—fueling decades of junk science
Screenshot-2026-11-06-at-12.33.30-PM
Freaked out: Is it ethically okay to create animals with human tissue–including from the brain to help save lives?
Glossy Chocolate in Glass Petri Dish
Chocolate-making cocoa beans are increasingly in short supply. There may be a biotech fix
Colorful GLP-1 Pens with Clocks_tagger
Biohacker influencers are claiming GLP-1 weight loss drugs extend lifespan. One mice experiment suggests there may be some truth to the claim
Screenshot-2026-11-13-at-11.57.01-AM
JAMA survey: Who’s most likely to embrace the RFK Jr.-fueled lie that vaccines cause autism? Men, adults 35–44, blacks and Republicans
Screenshot-2026-11-13-at-2.44.51-PM
Viewpoint: How will the Democratic sweep impact abortion rights 
Paper Field Portraits with Distant Barn (1)
Viewpoint: After MAHA-Republican election debacle, controversial campaigner Zen Honeycutt looks to sympathetic Democrats to promote her anti-chemical agenda
Rustic Skillet of Raw Brains
‘Weird food’? Testicle- and brain-eating, supplement-gulping MAHA health food enthusiasts defend their ‘natural’ diets
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.